Jacquin, Jean-Philippe <br/><br/>
Phase II trial of pegylated liposomal doxorubicin in combination with gemcitabine in metastatic breast cancer patients.  [electronic resource] 

 -  American journal of clinical oncology  Feb 2012 
 - 18-21 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study 
<br/><br/><label>ISSN: </label>1537-453X 
<br/><br/><label>Standard No.: </label>10.1097/COC.0b013e3182005783  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Antineoplastic Combined Chemotherapy Protocols--administration & dosage<br/>Breast Neoplasms--drug therapy<br/>Deoxycytidine--administration & dosage<br/>Disease-Free Survival<br/>Doxorubicin--administration & dosage<br/>Drug Administration Schedule<br/>Female<br/>Hand-Foot Syndrome--etiology<br/>Humans<br/>Injections, Intravenous<br/>Middle Aged<br/>Neutropenia--chemically induced<br/>Polyethylene Glycols--administration & dosage<br/>Stomatitis--chemically induced<br/>Thrombocytopenia--chemically induced<br/>Treatment Outcome<br/>Gemcitabine